Artemis Medicare Services logo

Artemis Medicare Services financials: balance sheet, profit and loss, cash flow

NSE: ARTEMISMEDBSE: 542919Healthcare ServicesSmall Cap

Artemis Medicare Services Limited · Face value ₹1 · Listed Jan 2020
Last close ₹293.20down ₹4.75 (1.59%)BSE ₹292.20

Share price at the NSE close on 30 Oct 2026. Previous close ₹297.95.

30 Oct: open ₹297.95, high ₹302.15, low ₹287.70

52-week range of traded prices to 30 Oct 2026
₹203.35Low, 30 Mar 2026₹378.80High, 25 Sep 2026
Market cap
₹4,642 Cr861st largest listed
P/E
40.46
P/B
4.69
Dividend yield
0.15%
ROE
12.3%
ROCE
12.5%
Debt to equity
0.24
Volume, NSE
1,63,55039.9% delivered

Artemis Medicare Services' financial statements for the 7 years to Mar 2026, consolidated: the company and its subsidiaries together, with the half year to Sep 2026 after them.

7 years at a glance

₹ crore, years to March.Artemis Medicare Services annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
5651976Mar 204086.2108Mar 2155531184Mar 2273738242Mar 2387949254Mar 2493782246Mar 251,081104227Mar 26
Peak revenue ₹1,081 Cr, year to Mar 2026; lowest ₹408 Cr, year to Mar 2021

Operating and net margin, per cent

  • Operating margin
  • Net margin
17.4%1.5%10.9%8.6%12.2%12.7%15.1%16.2%17.4%3.4%1.5%5.7%5.2%5.6%8.8%9.6%Mar 20Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,081
  2. Materials and goods−254
  3. Employee costs−166
  4. Other expenses−473
  5. Operating profit188
  6. Depreciation−48
  7. Other income+30
  8. One-off items−3.1
  9. Finance costs−28
  10. Profit before tax139
  11. Tax−35
  12. Net profit104

What the company owns

  • Plant, investments and other assets₹1,089 Cr
  • Cash and bank₹206 Cr
  • Receivables₹120 Cr
  • Inventory₹13 Cr

What pays for it: net worth and liabilities

  • Net worth₹941 Cr
  • Borrowings₹227 Cr
  • Other liabilities₹163 Cr
  • Owed to suppliers₹98 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Sep 2026, the latest four quarters added.Artemis Medicare Services quarterly results

₹ croreMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 12 MayMar 2026Filed 8 MaySep 2026Twelve monthsFiled 30 Oct
Revenue from operations5654085557378799371,0811,150
504373487643746785893943
Materials and goods bought139116342195219227254248
Employee costs10384104121139148166175
Other expenses26117341328388409473519
Operating profit before depreciation61356794133152188207
Operating margin10.9%8.6%12.2%12.7%15.1%16.2%17.4%18.0%
Materials, % of revenue24.6%28.5%61.6%26.4%24.9%24.3%23.5%21.6%
Employee costs, % of revenue18.3%20.6%18.8%16.4%15.8%15.8%15.4%15.2%
Other expenses, % of revenue46.2%42.3%7.4%44.5%44.2%43.7%43.8%45.1%
Depreciation and amortisation2322223140454852
Operating profit after depreciation3914456392107140155
Other income54477333029
Finance costs1313122031322827
Profit before one-off items and tax314375168108142157
One-off items030000−3−3
Profit before tax318375168108139154
11161319253539
19631384982104115
Other comprehensive income00010000
Total comprehensive income19731394982104115
Net margin3.4%1.5%5.7%5.2%5.6%8.8%9.6%10.0%

Balance sheet

Consolidated, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 12 MayMar 2026Filed 8 MaySep 2026Half yearFiled 30 Oct
314322361408455844941996
313320359403448838935989
Share capital1313131314141616
Reserves300307346390435824919974
Belonging to outside owners of subsidiaries02256666
76108184242254246227242
158119138206185216211263
115160210291332298277339
Total assets5866007109059721,3571,4291,598
4694915837357918191,0621,121
118109127170180539367477
Net debt6177156191192−15021−25
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only.

Cash flow

Consolidated, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 12 MayMar 2026Filed 8 MaySep 2026Half year
2760127109146132112
2576130115159149119
−12030−143−403
Receivables19−20−22−4−10−21−40
Inventories1−3−240−3−4
Payables−1642977−122
Other working capital−161925−226−1525
Tax paid2−16−3−6−14−17−7
Capital spending351091467393105112
Free cash flow−7−49−193652270
−37−107−158−87−385−90−121
184438−30267−50−6
Dividends paid0006667
Shares bought back0000000
Shares issued1132000
Net change in cash8−37−827−8−14
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the year to Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Artemis Medicare Services dividend history

₹ per shareMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 12 MayMar 2026Filed 8 May
₹1.50₹0.49₹2.40₹2.89₹3.62₹5.37₹6.56
As stated that year₹14.95₹4.90₹2.40₹2.89₹3.62₹5.37₹6.56
₹1.50₹0.49₹2.29₹2.79₹3.53₹5.31₹6.56
Dividend per share–––₹0.45₹0.45₹0.45₹0.45
₹23.66₹24.19₹27.15₹30.06₹33.00₹60.88₹59.04
Dividend payout–––15.9%12.4%7.5%6.9%
Shareholder yield–−0.5%−0.1%−0.4%0.2%0.2%0.2%
Market cap at the year end (₹ crore)1812926089112,3083,7633,253
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Consolidated, years to March.Artemis Medicare Services PE ratio and valuation

RatioMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 12 MayMar 2026Filed 8 May
Revenue growth–−27.7%35.8%32.9%19.1%6.6%15.4%
Operating profit growth–−42.7%91.6%39.3%41.3%14.4%24.0%
Net profit growth–−68.3%409.8%21.0%29.3%67.2%26.2%
Earnings per share growth–−67.2%389.8%20.4%25.3%48.3%22.2%
6.3%1.9%9.4%10.0%11.5%12.8%11.7%
–−4.4 pts7.4 pts0.6 pts1.6 pts1.3 pts−1.2 pts
From the net margin–−3.6 pts5.4 pts−0.9 pts0.8 pts6.7 pts1.1 pts
From asset turnover–−0.8 pts1.7 pts0.7 pts0.3 pts−2.6 pts−0.5 pts
From borrowing–0.0 pts0.3 pts0.9 pts0.5 pts−2.8 pts−1.8 pts
Return on capital employed10.0%3.2%8.3%9.7%13.0%9.8%12.0%
Cash conversion–442.5%189.7%334.5%221.5%177.2%127.2%
Interest cover3.01.13.83.23.03.35.1
Debt to equity0.240.330.510.590.560.290.24
Receivable days49494846393940
Inventory days28301326171619
Payable days196064165158162142
Cash conversion cycle, days−11879−3−93−102−107−82
Working capital days−29−36−11−29−17−14−4
Asset turnover0.960.690.850.910.940.800.78
Assets per rupee of net worth1.871.871.932.122.201.811.57
Sales per rupee of plant1.691.271.251.431.441.431.50
Capital spending to depreciation–1.604.914.721.802.062.18
Plant being built, % of plant in use16.7%25.2%14.0%18.4%5.5%5.9%3.9%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
7.4%
Cash from operations against operating profit
70.1%
Measure5 years3 years
Revenue growth, yearly rate21.5%13.6%
Profit growth, yearly rate75.9%39.7%
Return on equity, average11.1%12.0%
Return on capital employed, average10.6%11.6%
Operating margin, average14.7%16.2%
Net margin, average7.0%8.0%
Asset turnover, average0.860.84
Cash conversion cycle, days, average−77−97
Interest cover, average3.73.8
Debt to equity, average0.440.36

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations573386132
Cash from investing−828−562−90
Cash from financing269187−50
Capital spending526271105
Dividends paid18186
Shares bought back000
Shares issued for cash620
Borrowings raised62246064
Borrowings repaid19514778

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––66775
Altman Z-scorePublished threshold 1.812.242.122.722.734.546.566.17
Beneish M-scorePublished threshold −1.78–−2.76−1.96−3.12−2.81−2.71−1.99
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–2.7512.078.552.9127.654.44
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––2.832.492.251.64
Receivables growth less revenue growthOur threshold 0 percentage points–−0.85−1.68−5.86−17.480.222.64
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–5.65−164.6755.84−40.14−5.0622.88
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–0.02−0.13−0.200.061.98−0.78
Assets under construction, years of additionsOur threshold 2 years of additions–8.690.430.930.250.430.24
Effective tax ratePublished threshold 17.16 per cent36.4718.2015.5524.8928.2123.6725.48
Tax charged less tax paid, % of profitOur threshold 10 percentage points––−27.3619.2119.6910.8113.57
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
30 Sep 2026CARE Ratings LimitedFund-based - LT/ ST-Working Capital LimitsCARE A / CARE A2+Review, Re-affirmStable45
30 Sep 2026CARE Ratings LimitedTerm Loan-Long TermCARE AReview, Re-affirmStable343.15
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.